140 related articles for article (PubMed ID: 35364344)
1. The inhibitory effects of MIF on accumulation of canine degenerative myelopathy-associated mutant SOD1 aggregation.
Nomura S; Kobatake Y; Takashima S; Kamishina H; Urushitani M; Nishii N
Res Vet Sci; 2022 Oct; 147():7-11. PubMed ID: 35364344
[TBL] [Abstract][Full Text] [Related]
2. Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model.
Crisp MJ; Beckett J; Coates JR; Miller TM
Exp Neurol; 2013 Oct; 248():1-9. PubMed ID: 23707216
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic structural vulnerability in the hydrophobic core induces species-specific aggregation of canine SOD1 with degenerative myelopathy-linked E40K mutation.
Hashimoto K; Watanabe S; Akutsu M; Muraki N; Kamishina H; Furukawa Y; Yamanaka K
J Biol Chem; 2023 Jun; 299(6):104798. PubMed ID: 37156398
[TBL] [Abstract][Full Text] [Related]
4. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
5. Localization of a mutant SOD1 protein in E40K-heterozygous dogs: Implications for non-cell-autonomous pathogenesis of degenerative myelopathy.
Kobatake Y; Sakai H; Tsukui T; Yamato O; Kohyama M; Sasaki J; Kato S; Urushitani M; Maeda S; Kamishina H
J Neurol Sci; 2017 Jan; 372():369-378. PubMed ID: 27838005
[TBL] [Abstract][Full Text] [Related]
6. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence of propagation of superoxide dismutase-1 protein aggregation in canine degenerative myelopathy.
Tanaka N; Kimura S; Kamatari YO; Nakata K; Kobatake Y; Inden M; Yamato O; Urushitani M; Maeda S; Kamishina H
Vet J; 2021 Aug; 274():105710. PubMed ID: 34166783
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms of Aggregation of Canine SOD1 E40K Amyloidogenic Mutant Protein.
Wakayama K; Kimura S; Kobatake Y; Kamishina H; Nishii N; Takashima S; Honda R; Kamatari YO
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615350
[TBL] [Abstract][Full Text] [Related]
9. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS.
Shvil N; Banerjee V; Zoltsman G; Shani T; Kahn J; Abu-Hamad S; Papo N; Engel S; Bernhagen J; Israelson A
Cell Death Dis; 2018 Jan; 9(2):107. PubMed ID: 29371591
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
Israelson A; Ditsworth D; Sun S; Song S; Liang J; Hruska-Plochan M; McAlonis-Downes M; Abu-Hamad S; Zoltsman G; Shani T; Maldonado M; Bui A; Navarro M; Zhou H; Marsala M; Kaspar BK; Da Cruz S; Cleveland DW
Neuron; 2015 Apr; 86(1):218-32. PubMed ID: 25801706
[TBL] [Abstract][Full Text] [Related]
11. MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
Alaskarov A; Barel S; Bakavayev S; Kahn J; Israelson A
Sci Rep; 2022 Jun; 12(1):9570. PubMed ID: 35688953
[TBL] [Abstract][Full Text] [Related]
12. Species-specific consequences of an E40K missense mutation in superoxide dismutase 1 (SOD1).
Draper ACE; Wilson Z; Maile C; Faccenda D; Campanella M; Piercy RJ
FASEB J; 2020 Jan; 34(1):458-473. PubMed ID: 31914665
[TBL] [Abstract][Full Text] [Related]
13. Protein disulphide isomerase is associated with mutant SOD1 in canine degenerative myelopathy.
Chang RC; Parakh S; Coates JR; Long S; Atkin JD
Neuroreport; 2019 Jan; 30(1):8-13. PubMed ID: 30422940
[TBL] [Abstract][Full Text] [Related]
14. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated spinal microRNAs induce aggregation of superoxide dismutase 1 protein in canine degenerative myelopathy.
Nakata K; Namiki M; Kobatake Y; Nishida H; Sakai H; Yamato O; Urushitani M; Maeda S; Kamishina H
Res Vet Sci; 2021 Mar; 135():479-485. PubMed ID: 33261827
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS.
Abu-Hamad S; Israelson A
Rare Dis; 2015; 3(1):e1061164. PubMed ID: 26459694
[TBL] [Abstract][Full Text] [Related]
17. Accumulation and aggregate formation of mutant superoxide dismutase 1 in canine degenerative myelopathy.
Nakamae S; Kobatake Y; Suzuki R; Tsukui T; Kato S; Yamato O; Sakai H; Urushitani M; Maeda S; Kamishina H
Neuroscience; 2015 Sep; 303():229-40. PubMed ID: 26162235
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.
Awano T; Johnson GS; Wade CM; Katz ML; Johnson GC; Taylor JF; Perloski M; Biagi T; Baranowska I; Long S; March PA; Olby NJ; Shelton GD; Khan S; O'Brien DP; Lindblad-Toh K; Coates JR
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2794-9. PubMed ID: 19188595
[TBL] [Abstract][Full Text] [Related]
19. Canine SOD1 harboring E40K or T18S mutations promotes protein aggregation without reducing the global structural stability.
Kimura S; Kamatari YO; Kuwahara Y; Hara H; Yamato O; Maeda S; Kamishina H; Honda R
PeerJ; 2020; 8():e9512. PubMed ID: 32742795
[TBL] [Abstract][Full Text] [Related]
20. In vitro evidence consistent with an interaction between wild-type and mutant SOD1 protein associated with canine degenerative myelopathy.
Qi Y; Montague P; Loney C; Campbell C; Shafie INF; Anderson TJ; McLaughlin M
Eur J Neurosci; 2019 Dec; 50(12):3896-3905. PubMed ID: 31336405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
